The use of aspirin for primary prevention has fallen out of favor following changes to clinical guidelines prompted by results from multiple trials: now, an analysis from one of those studies ...

Elderly people with the lowest and highest hemoglobin concentrations (the component of red blood cells that carries oxygen) are at increased risk of death, according to a study in the October 24 issue ...

Anemia in very elderly people aged 85 and older appears to be associated with an increased risk of death, according to a new study. Anemia in very elderly people aged 85 and older appears to be ...

A recent follow-up analysis of data from an international, National Institutes of Health-funded clinical trial suggests daily low-dose aspirin increases the risk of anemia in people age 65 years and ...

Over a median of 4.7 years, the incidence of anemia was 51.2 events per 1,000 person-years in the aspirin group compared with 42.9 events per 1,000 person-years in the placebo group (HR 1.20, 95% CI 1 ...

Denosumab for the treatment of bisphosphonate-refractory hypercalcemia of malignancy (HCM). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full ...

RICHMOND, Calif.--(BUSINESS WIRE)--BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, today announced that it has commenced a ...

Dear Dr. Gott: My husband is 76 years old. He takes lots of medications, including warfarin. He is a little anemic. His hemoglobin is 11 and he has no energy and sleeps a lot. He has to push himself ...